|
ZNF749 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.07310049735077E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.50160000492272E-08 |
| Normal-vs-Stage2 |
2.03579999999981E-05 |
| Normal-vs-Stage3 |
2.67550004373618E-09 |
| Normal-vs-Stage4 |
8.90780005313729E-09 |
| Stage1-vs-Stage2 |
9.967800E-01 |
| Stage1-vs-Stage3 |
1.112180E-01 |
| Stage1-vs-Stage4 |
5.465900E-02 |
| Stage2-vs-Stage3 |
2.592400E-01 |
| Stage2-vs-Stage4 |
1.390620E-01 |
| Stage3-vs-Stage4 |
7.033800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.85519996534589E-09 |
| Normal-vs-AfricanAmerican |
1.796120E-02 |
| Normal-vs-Asian |
1.15690000002111E-06 |
| Caucasian-vs-AfricanAmerican |
2.120600E-01 |
| Caucasian-vs-Asian |
5.657200E-01 |
| AfricanAmerican-vs-Asian |
1.564780E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.60680005254233E-09 |
| Normal-vs-Female |
7.70870034472182E-10 |
| Male-vs-Female |
5.299400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.50650000030339E-07 |
| Normal-vs-Age(41-60Yrs) |
7.42719996615904E-10 |
| Normal-vs-Age(61-80Yrs) |
2.64010002748449E-09 |
| Normal-vs-Age(81-100Yrs) |
3.591900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.057600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.226620E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.506400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.263400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.520000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.690200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.171800E-04 |
| Classical-VS-Follicular |
1.872440E-01 |
| Classical-VS-Other |
6.546400E-01 |
| Classical-VS-Normal |
1.22719999717802E-08 |
| Tall-VS-Follicular |
2.922400E-02 |
| Tall-VS-Other |
5.247000E-01 |
| Tall-VS-Normal |
9.605205519847E-11 |
| Follicular-VS-Other |
9.902600E-01 |
| Follicular-VS-Normal |
3.44799999663081E-08 |
| Other-VS-Normal |
2.030000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.5207000365366E-09 |
| Normal-vs-N1 |
1.90289999979498E-07 |
| N0-vs-N1 |
6.279600E-01 |
|
|
